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Abstract
Background: Taiwan has been considered free from canine parvovirus type 2c (CPV-2c) based on the last report of
canine parvovirus type 2 (CPV-2) surveillance. However, since January 2015, the first report of CPV-2c in a puppy has
occurred in Taiwan. There is currently limited information about the CPV-2c variant in Taiwan. In the present study,
we characterized the previously unidentified CPV-2c variant and investigated the distribution of CPV-2 variants in
Taiwan.
Methods: During January 2014 to April 2016, fecal or rectal swab samples from 99 dogs with suspected CPV-2
infection in Taiwan were collected. Eighty-eight were identified as being either CPV-2a, −2b or -2c variants positive
by real-time PCR and sequence analysis.
Results: Sequence analysis of the 88 isolates confirmed CPV-2c as the dominant variant (54.6 %), followed by
CPV-2b (26.1 %) and CPV-2a (19.3 %). Phylogenetic analysis demonstrated that the recent CPV-2c variants are similar
to the Chinese CPV-2c strain but can be considered as novel Asian CPV-2c isolates.
Conclusion: The present study provides evidence for the existence of a novel CPV-2c variant in Taiwan.
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Background
Canine parvovirus type 2c (CPV-2c) was first detected in
Italy in 2000 [1]. Antigenic differences among CPV-2a,
−2b, and -2c are observed only in residue 426 (Asn in
2a, Asp in 2b, and Glu in 2c) [2], which is located in the
major VP2 antigenic site of the parvovirus [3]. The
functions of capsid protein VP2 include facilitating
receptor binding, controlling host range [4], and eliciting
neutralizing antibodies [3]. Although CPV-2c infection
results in almost the same clinical signs as for CPV-2a
and CPV-2b, including anorexia, vomiting, acute
gastroenteritis, and hemorrhagic diarrhea, infection by
CPV-2c has been reported to be indicative of a more se-
vere disease [5, 6].
A retrospective analysis revealed that the oldest
CPV-2c strain was identified in Germany in 1996 [7].
Another retrospective analysis revealed that the
frequency of CPV-2 variants underwent rapid fluctuation
in Italy between 1995 and 2005, with CPV-2c very rap-
idly replacing CPV-2b [8]. CPV-2c infection has not only
been observed in Italy, but it is also widely distributed in
other European countries [7, 9, 10], including Germany,
Portugal [11], Spain [12], Belgium, France, Greece [13],
Bulgaria [14], Sweden [15], Turkey [16], and the United
Kingdom. In recent years, CPV-2c has also been found
to be widespread in Tunisia [17], the USA [18], Uruguay
[19], Brazil [20], Argentina [21], Ecuador [5], Mexico
[22], and Morocco [23]. Surprisingly, since the first
reported finding in Vietnam in 2004, the CPV-2c variant
has not been prevalent in Asia [24]. Indeed, only a few
CPV-2c strains have been isolated in India [25] and
China [26–28], with either CPV-2a or -2b being preva-
lent in Asian countries thus far [25–27, 29–42].
In Taiwan, as in other Asian countries, both the CPV-2a
and -2b genotypes constitute the prevalent CPV-2 field
strains circulating in the last two decades [30, 31, 39, 41].
Before the present study, no report indicated the
occurrence of a CPV-2c variant in Taiwan [30, 31, 39, 41].
However, in January 2015, the first report of CPV-2c in a
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puppy in Taiwan occurred, and there is to date limited
information about the CPV-2c variant in Taiwan. In the
present study, we examined this CPV-2c variant and
investigated the distribution of CPV-2 variants in Taiwan.
Methods
Specimen collection
Clinical specimens (feces and/or rectal swab) were
collected from 99 dogs with suspected CPV-2 infection
from northern, central, southern, and eastern Taiwan
from January 2014 to April 2016. These samples were
mainly acquired from dogs with diarrhea and/or bloody
diarrhea. The year of sampling and the age, clinical
history, and CPV-2 types of the sampled dogs are
summarized in Additional file 1.
CPV-2 screening and partial VP2 gene amplification
Viral DNA was extracted from the clinical samples
(either feces or rectal swab) and screened for CPV-2 by
real-time PCR, as described by Lin et al. [43]. Samples
showing positive results for either type of specimen were
included in this study. The partial VP2 gene of CPV-2
was amplified by PCR, as described by Buonavoglia et al.
[1], and the DNA fragments were purified and sequenced
as described by Lin et al. [41].
Sequence and phylogenetic analyses
The VP2 DNA sequences of our samples were compared
to those of reference FPV (M38246), CPV-2 (M38245),
CPV-2a (M24003), CPV-2b (M74849), new CPV-2a (JX
048605), new CPV-2b (JX048607), and CPV-2c (JF41
4818, JF414820, JF414822, FJ005247, GU380303, GU38
0305, KR611522, KT074339, KT162005, KF149962,
FJ005196, GQ865518, FJ222821, FJ005213, FJ005238,
FJ005214, KC196099, KM457119, AB120727, KP071956,
KR559893, FJ005235). Multiple alignments of the nucleic
acid and amino acid sequences were performed using
the Clustal W method and the MegAlign program
(DNASTAR, Madison, WI, USA). Phylogenetic analyses
were performed with the maximum likelihood method
using MEGA 6, version 6.06.
Results
Polymerase chain reaction (PCR) amplification and
genotype analysis
A total of 88 samples from 99 dogs were positive for
CPV-2. Of the 88 CPV-2 isolates, 17, 23, and 48 were
identified as CPV-2a (19.3 %), CPV-2b (26.1 %), and
CPV-2c (54.6 %), respectively. First, we observed the
CPV-2c variant collected in January 2015 (Additional file 1,
Fig. 1). This variant rapidly spread throughout the
Taiwanese dog population, and detection rates were
53.1 % (26/49) and 68.8 % (22/32) in 2015 (January
to December) and 2016 (January to April), respectively
(Fig. 1). Taken together, our data revealed co-circulation
of CPV-2a, −2b, and -2c on the island, and CPV-2c was
identified as the current dominant variant.
Geographical distribution of the CPV-2 variants
Of the 17 CPV-2a variants, 2 (11.8 %), 7 (41.2 %), and 8
(47.0 %) isolates were collected from central, southern,
and eastern Taiwan, respectively (Fig. 2). Of the 23
CPV-2b variants, 10 (43.5 %), 8 (34.8 %), 4 (17.4 %), and
1 (4.3 %) isolates were collected from northern, central,
southern, and eastern Taiwan, respectively (Fig. 2). Of
the 48 CPV-2c variants, 13 (27.1 %), 16 (33.3 %), 13
(27.1 %) and 6 (12.5 %) isolates were collected from
northern, central, southern, and eastern Taiwan,
respectively (Fig. 2). Taken together, our results showed
distribution of the CPV-2c variant throughout Taiwan.
Fig. 1 Distribution of CPV-2 variants in Taiwan according to month between January 2014 and April 2016
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DNA sequence analysis
Partial VP2 nucleotide sequences were analyzed using
DNASTAR software, revealing 96.6–100 %, 98.3–100 %,
and 98.5–100 % homology within local CPV-2a isolates,
CPV-2b isolates, and CPV-2c isolates, respectively
(Table 1). The same nucleotide sequences for local CPV-2c
isolates exhibited 96.9–99 % and 97.5–99.2 % homology
with those of the CPV-2a and -2b isolates, respectively
(Table 1). In contrast to the low nucleotide sequence
similarity between prototype CPV-2c (FJ222821, from
Italy) and CPV-2c from Taiwan (97.9–99.0 %), the
homology levels between our analyzed CPV-2c isolates
(97.7–100 %) and Chinese CPV-2c (GU380303,
GU380305, KR611522, KT074339, KT162005) appeared
to be much higher (Table 1).
Amino acid sequence analysis
Comparisons among the 88 isolates and 12 reference
strains at amino acids 267–440 are presented in Table 2.
For the partial VP2 analysis, 17 sequences with an Asn
at position 426 were classified as CPV-2a. All of the
CPV-2a strains show substitution at position 324 (Tyr to
Ile) caused by mutation of TAT to ATT at nucleotide
positions 970–972 of the VP2 gene (Table 2). Interest-
ingly, five CPV-2a strains from eastern Taiwan are iden-
tical in nucleotide sequence but have distinctive residues
(Phe267Tyr, Tyr324Ile, and Thr440Ala) (Table 2). Four
CPV-2b strains are identical to the prototype of CPV-2b
(Table 2). Fifteen of the 19 CPV-2b strains show substi-
tution at position 267 (Phe to Tyr) and 324 (Tyr to Ile),
and four CPV-2b strains only show substitution at pos-
ition 324 (Tyr to Ile). Glu426, which is unique to strain
CPV-2c, was first observed in 48 samples in this study.
Fig. 2 Geographical distribution of CPV-2 variants collected from the
dog population between January 2014 and April 2016









Taiwanese CPV-2a 96.6–100.0 98.3–99.6 96.9–99.0
Taiwanese CPV-2b 98.3–100.0 97.5–99.2
Taiwanese CPV-2c 98.5–100.0
Chinese CPV-2ca 97.7–100.0
Italy CPV-2c (FJ222821) 97.9–99.0
aAccession numbers: GU380303, GU380305, KR611522, KT074339, KT162005
Table 2 Amino acid mutations of the VP2 gene sequences
analyzed in this study
Isolate Amino acid at position
267 297 324 370 420 426 440
CPV2 (M38245) Phe Ser Tyr Gln Phe Asn Thr
Partial-length VP2
CPV-2a-1a (n = 12) Phe Ala Ile Gln Phe Asn Thr
CPV-2a-2b (n = 5) Tyr Ala Ile Gln Phe Asn Ala
CPV-2b-1c (n = 4) Phe Ala Tyr Gln Phe Asp Thr
CPV-2b-2d (n = 15) Tyr Ala Ile Gln Phe Asp Thr
CPV-2b-3e (n = 4) Phe Ala Ile Gln Phe Asp Thr
CPV-2c-1f (n = 38) Tyr Ala Ile Arg Phe Glu Thr
CPV-2c-2g (n = 10) Tyr Ala Ile Arg Ser Glu Thr
aKX396349, KX396353, KX396354, KX396356, KX396359, KX396365, KX396375,
KX396377, KX396378, KX396385, KX396388, KX396419
bKX396376, KX396390, KX396400, KX396404, KX396415
cKX396348, KX396361, KX396383, KX396420
dKX396368, KX396369, KX396370, KX396371, KX396372, KX396373, KX396374,
KX396386, KX396387, KX396405, KX396406, KX396407, KX396409,
KX396417, KX396421
eKX396350, KX396351, KX396352, KX396382
fKX396355, KX396357, KX396358, KX396360, KX396362, KX396363, KX396364,
KX396366, KX396367, KX396379, KX396380, KX396381, KX396384, KX396389,
KX396391, KX396392, KX396393, KX396394, KX396395, KX396396, KX396397,
KX396399, KX396401, KX396402, KX396403, KX396408, KX396410, KX396411,
KX396412, KX396413, KX396414, KX396422, KX396424, KX396425, KX396427,
KX396433, KX396434, KX396435
gKX396398, KX396416, KX396418, KX396423, KX396426, KX396428, KX396429,
KX396430, KX396431, KX396432
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One unique amino acid substitution was found in the all
CPV-2c isolates (Gln370Arg) (Table 2), which is caused
by mutation of CCA to CGA at nucleotide positions
1,108-1,110 of the VP2 gene. All CPV-2c variants also
show amino acid substitution at position 267 (Phe to
Tyr) and 324 (Tyr to Ile). Interestingly, 10 of 48 CPV-2c
variants show a unique substitution on Phe420Ser.
Phylogenetic analysis
The phylogenetic tree of the partial VP2 gene for the 88
isolates and 28 reference strains was generated using the
maximum likelihood method with MEGA 6, version
6.06. Two clusters based on the phylogenetic relation-
ship of the partial VP2 gene of CPV-2c were detected
(Fig. 3). The first cluster comprises prototype isolates,
European isolates, American isolates, and Asian isolates
of CPV-2c. The second cluster consists of all 48 Taiwanese
isolates from this study and 4 Chinese isolates of CPV-2c
(Fig. 3). To date, these novel CPV-2c isolates have only
been detected in China and Taiwan. Our findings demon-
strated that the recent CPV-2c isolates in Taiwan are more
genetically similar within the VP2 gene to Chinese CPV-2c
strains than to prototype strains of CPV-2c.
Discussion
This is the first study to demonstrate the CPV-2c variant
in Taiwan. Previous studies have shown that both the
CPV-2a and -2b genotypes constitute the prevalent
CPV-2 field strains circulating in Taiwan, and no CPV-
2c cases were reported in the last two decades (Table 3).
In our continuous surveillance and sequence analysis,
Taiwan was considered to be free of CPV-2c. However,
since January 2015, one case of CPV-2c occurred in a
puppy in Taiwan. The CPV-2c variant appears thus far
to have the highest detection rate in the dog population
of Taiwan. Similar results have shown that CPV-2c re-
placed the previous circulation of CPV-2 strains in Italy
[8], Uruguay [19], Argentina [21], Brazil [20], and the
United States [44]. Interestingly, comparative VP2 gen-
ome analysis of the isolated CPV-2c reference revealed
that the partial VP2 genome sequence of the Taiwanese
strain is similar (97.7–100 %) to that of Chinese CPV-2c
strains. Our results indicate that the recent CPV-2c iso-
late from Taiwan shares a common evolutionary origin
with the Chinese CPV-2c strains and should be classified
as novel Asian CPV-2c isolates. According to genotype
Fig. 3 Phylogenetic analysis of nucleotide sequences of the partial
VP2 genes of CPV-2 strains (522 bp). The phylogenetic tree was
constructed using the maximum likelihood method with bootstrap
analysis (n = 1,000) to determine the best fitting tree. CPV variants
are indicated by □, ●, ○, and ▲ for CPV-2, 2a, 2b, and 2c,
respectively. The gray diagram represents the Taiwanese CPV-2
variants in this study
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surveillance between Taiwan [30, 31, 39, 41] and China
[26–28, 37, 45–48], CPV-2c was first detected in China
in 2009 [28]. In contrast, no CPV-2c variant was
observed in studies conducted over the last two decades
in Taiwan (Table 3). In addition, the Taiwanese CPV-2c
variant is more closely related to the Chinese CPV-2c
strains than the recent Taiwanese CPV-2a (JX048605)
and -2b (JX048607) isolates (Fig. 3). Taken together, our
results suggest that the Taiwanese CPV-2c may be
present due to import from China at some time between
the end of 2014 to early 2015 rather than to evolution of
existing CPV-2a or -2b genotypes. An ongoing investiga-
tion and complete VP2 genome sequence analysis is
needed to trace the genetic evolution of this novel
CPV-2c variant.
The recent Taiwanese CPV-2a is composed of two
divergent lineages that have different ancestors. Most
Taiwanese CPV-2a strains belong to the recent Taiwanese
lineage of CPV-2a, sharing a common amino acid substi-
tution (Tyr324Ile). The second lineage of the Taiwanese
CPV-2a variant is more closely related to recent
Uruguayan and Chinese CPV-2a strains and has distinct-
ive amino acid substitutions of Phe267Tyr, Tyr324Ile, and
Thr440Ala. This new CPV-2a variant was discovered in
China and Uruguay between 2006 and 2009 and in 2010
[49], respectively. This is the first detection of this lineage
of CPV-2a in eastern Taiwan in 2015. However, this new
CPV-2a variant recently emerged in Uruguay and under-
went clonal expansion [49]. An ongoing investigation is
aimed at determining whether this new CPV-2a variant
will replaced the CPV-2c variant in the Taiwanese dog
population.
Amino acid substitution of Tyr324Ile has been
observed in Korea [32, 34], China [26, 27, 37, 45–48],
Thailand [36], Uruguay [49, 50], Japan [38], Taiwan
[39, 41], and India [40, 42]. Interestingly, the frequency of
the Ile324 variant has reached a high prevalence among
Taiwanese CPV-2 isolates (94.5 %), and our results revealed
that this variant is not only present among Taiwanese
CPV-2a strains but also CPV-2b and -2c strains. In
addition, this study reports for the first time the amino acid
substitution of Phe267Tyr in Taiwan. Surprisingly, all of
the Tyr267 variants among Taiwanese CPV-2a, −2b,
and −2c strains contain the amino acid substitution
of Tyr324Ile. Our review of sequence analysis in the
literature indicated that this phenomenon is also
found in Uruguay [51]. The functions of CPV-2
residues 267 and 324 are still unknown and remain
to be elucidated.
The substitution of Gln370Arg is unique to the
Taiwanese CPV-2c strains, and this mutation is also
observed in Chinese panda parvovirus [52] and Chinese
CPV-2c strains [26, 27]. Residue 359 and 375 constitute a
flexible surface loop of the capsid protein that is adjacent to
a double Ca2+-binding site; this region is essential for virus
infectivity, and changes are correlated with the ability
of the virus to cause erythrocyte hemagglutination
[53]. Therefore, it remains to be investigated whether
Gln370Arg substitution causes antigenic alterations.
Mutation of residue 420 had been reported in Brazilian
reference CPV-2c strains (Phe420Leu) [54]. In the
present study, we detected 10 CPV-2c strains with a
unique change at the same position, yet Phe420Ser was
unique in these 10 Taiwanese CPV-2c strains. Therefore,
further studies focusing on potential variants of the
CPV-2c strains should be conducted to elucidate the
relationship between Phe420Ser substitution and viral
pathogenicity.
Although several studies have demonstrated the
efficacy of the current CPV-2 vaccine against CPV-2c
infection [55, 56], some evidence suggests that dogs with
the complete vaccination program still suffer from CPV-
2c [6]. In the present study, four of 22 CPV-2c-diseased
dogs died despite vaccination (C104-030, C104-031,
C104-042, C104-216) (Additional file 1). Among those
that died, three were under 6 months of age. Surpris-
ingly, despite having undergone the complete vaccin-
ation program, one adult dog (strain no. C104-216) was
infected by this novel CPV-2c variant. Therefore, co-
infection with other diseases needs to examined, and the
efficacy of the current vaccine against this novel CPV-2c
variant remains to be evaluated, especially in regard to
the amino acid substitutions observed in this novel
CPV-2c variant compared to the CPV-2c prototype.
Conclusions
This is the first report to identify a novel CPV-2c variant
in Taiwan. The novel CPV-2c variant was found to be
Table 3 Review of CPV-2 genotyping in Taiwan
Study
period
Region of Taiwan Genotype of CPV-2 References
2a 2b 2c
1994–1995 North 10 1 0 Chang et al., 1996 [30]
2003–2004 Central 2 34 0 Wang et al., 2005 [31]
2011 South 35 19 0 Chou et al., 2013 [39]
2008–2012 North, Central, and South 15 13 0 Lin et al., 2014 [41]
2014–2016 North, Central, South, and East 17 23 48 This study
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distributed throughout Taiwan, revealing that this novel
CPV-2c variant is currently circulating on the island.
Phylogenetic analysis demonstrated that the recent
CPV-2c isolate from Taiwan shares a common evolu-
tionary origin with Chinese strains of CPV-2c, as classi-
fied into novel Asian CPV-2c isolates (Phe267Tyr,
Tyr324Ile, Gln370Arg). Continuous and intensive sur-
veillance of this novel CPV-2c is needed, especially in
previously disease-free countries.
Additional file
Additional file 1: The genotypes of 88 canine parvovirus type 2 isolates
collected from Taiwanese dogs. (DOCX 74 kb)
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